Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese populationPsychiatry and clinical neurosciences, 2024-06, Vol.78 (6), p.362-371 [Peer Reviewed Journal]2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13661 ;PMID: 38606661Full text available |
|
2 |
Material Type: Article
|
Seven‐plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi‐Institutional Collaborative Cohort StudyCancer science, 2024-02, Vol.115 (2), p.611-622 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.16020 ;PMID: 38041484Full text available |
|
3 |
Material Type: Article
|
Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trialCancer science, 2023-09, Vol.114 (9), p.3698-3707 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15888 ;PMID: 37434391Full text available |
|
4 |
Material Type: Article
|
Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407Cancer science, 2023-08, Vol.114 (8), p.3330-3341 [Peer Reviewed Journal]2023 Merck Sharp & Dohme LLC and The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 Merck Sharp & Dohme LLC and The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15816 ;PMID: 37183528Full text available |
|
5 |
Material Type: Article
|
Style changes before and after disease onset in the works of an ikebana (Japanese traditional flower arrangement) artist with semantic variant primary progressive aphasiaPsychiatry and clinical neurosciences, 2023-08, Vol.77 (8), p.460-461 [Peer Reviewed Journal]2023 The Authors. Psychiatry and Clinical Neurosciences © 2023 Japanese Society of Psychiatry and Neurology. ;2023 Japanese Society of Psychiatry and Neurology ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13571 ;PMID: 37254948Full text available |
|
6 |
Material Type: Article
|
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910Cancer science, 2023-08, Vol.114 (8), p.3352-3363 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15834 ;PMID: 37189003Full text available |
|
7 |
Material Type: Article
|
Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population‐based cohort studies in JapanCancer science, 2023-07, Vol.114 (7), p.2961-2972 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15805 ;PMID: 37013939Full text available |
|
8 |
Material Type: Article
|
Phylogenic position and low genomic diversity of “Candidatus Rickettsia kotlanii” inferred by complete genome sequences of two Japanese isolatesMicrobiology and immunology, 2023-06, Vol.67 (6), p.275-280 [Peer Reviewed Journal]2023 The Authors. published by The Societies and John Wiley & Sons Australia, Ltd. ;2023 The Authors. Microbiology and Immunology published by The Societies and John Wiley & Sons Australia, Ltd. ;2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0385-5600 ;EISSN: 1348-0421 ;DOI: 10.1111/1348-0421.13065 ;PMID: 36994930Full text available |
|
9 |
Material Type: Article
|
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY AsiaCancer science, 2023-06, Vol.114 (6), p.2664-2673 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15790 ;PMID: 36919757Full text available |
|
10 |
Material Type: Article
|
Language patterns in Japanese patients with Alzheimer disease: A machine learning approachPsychiatry and clinical neurosciences, 2023-05, Vol.77 (5), p.273-281 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13526 ;PMID: 36579663Full text available |
|
11 |
Material Type: Article
|
Disparities among Japanese municipalities in recommendations for routine and catch‐up HPV vaccinationsCancer science, 2023-05, Vol.114 (5), p.2139-2144 [Peer Reviewed Journal]2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15748 ;PMID: 36747329Full text available |
|
12 |
Material Type: Article
|
Phase 1 trial of zolbetuximab in Japanese patients with CLDN18.2+ gastric or gastroesophageal junction adenocarcinomaCancer science, 2023-04, Vol.114 (4), p.1606-1615 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15684 ;PMID: 36478334Full text available |
|
13 |
Material Type: Article
|
Anxiety, depression, and posttraumatic stress symptoms of Japanese nationals half a year after the 2022 conflict in UkrainePsychiatry and clinical neurosciences, 2023-03, Vol.77 (3), p.190-191 [Peer Reviewed Journal]2022 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology ;2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1323-1316 ;EISSN: 1440-1819 ;DOI: 10.1111/pcn.13507 ;PMID: 36370054Full text available |
|
14 |
Material Type: Article
|
Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatmentCancer science, 2023-03, Vol.114 (3), p.1037-1044 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15663 ;PMID: 36394119Full text available |
|
15 |
Material Type: Article
|
Mitochondrial DNA haplogroup M7: A predictor of poor prognosis for colorectal cancer patients in Chinese populationCancer science, 2023-03, Vol.114 (3), p.1056-1066 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15654 ;PMID: 36382493Full text available |
|
16 |
Material Type: Article
|
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumorsCancer science, 2023-02, Vol.114 (2), p.574-585 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15486 ;PMID: 35838190Full text available |
|
17 |
Material Type: Article
|
Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancerCancer science, 2023-01, Vol.114 (1), p.271-280 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2023 John Wiley & Sons, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15518 ;PMID: 36254756Full text available |
|
18 |
Material Type: Article
|
Abemaciclib plus fulvestrant in East Asian women with HR+, HER2− advanced breast cancer: Overall survival from MONARCH 2Cancer science, 2023-01, Vol.114 (1), p.221-226 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;COPYRIGHT 2023 John Wiley & Sons, Inc. ;2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15600 ;PMID: 36168844Full text available |
|
19 |
Material Type: Article
|
p53 Arg72Pro polymorphism, adiposity status, and cancer risk: Two case‐cohorts within a Japanese prospective studyCancer science, 2022-12, Vol.113 (12), p.4385-4393 [Peer Reviewed Journal]2022 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15572 ;PMID: 36083231Full text available |
|
20 |
Material Type: Article
|
Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohortCancer science, 2022-12, Vol.113 (12), p.4267-4276 [Peer Reviewed Journal]2022 Janssen Research and Development, LLC. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022 Janssen Research and Development, LLC. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.15556 ;PMID: 36052883Full text available |